Search

Real-world evidence studies have indicated that cell-based quadrivalent influenza vaccine (QIVc) reduced physician office visits and hospitalizations due to influenza compared with conventional egg-based quadrivalent influenza vaccine (QIVe). Adjusted results show that rVE for QIVc was significantly higher compared to QIVe for influenza-related hospitalizations/ER visits (9.36% [95%CI: 0.31%-17.58%]) and all-cause hospitalization (5.09% [95%CI: 2.98%-7.16%]). Conclusions QIVc reduced influenza-related and respiratory-related hospitalizations/ER visits and all-cause hospitalizations compared to QIVe in subjects 50-64 years old during 2017/18 influenza season. [Extracted from the article]